#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA869056	A	Inhibition of rat liver CYP2E1	Rattus norvegicus	6	ALA1138063	tissue-based format	Scientific Literature
2.	ALA1015214	A	Inhibition of CYP2E1 in acetone-treated Sprague-Dawley rat liver microsomes assessed as hydroxylation of p-nitrophenol by spectrophotometry	Rattus norvegicus	11	ALA1152815	microsome format	Scientific Literature
3.	ALA1908251	A	Mechanism based inhibition of rabbit cytochrome P450 CYP2E1 measured by 7-EFC O-deethylation activity	Oryctolagus cuniculus	2	ALA1743341	single protein format	Scientific Literature
4.	ALA1908252	A	Mechanism based inhibition of rabbit cytochrome P450 CYP2E1 measured by P-nitrophenol (PNP) hydroxylase activity	Oryctolagus cuniculus	1	ALA1743341	single protein format	Scientific Literature
5.	ALA1908271	A	Mechanism based inhibition of rat cytochrome P450 CYP2E1	Rattus norvegicus	4	ALA1743341	single protein format	Scientific Literature
6.	ALA1908272	A	Mechanism based inhibition of rat cytochrome P450 CYP2E1 measured by P-nitrophenol (PNP) hydroxylase activity	Rattus norvegicus	1	ALA1743341	single protein format	Scientific Literature
7.	ALA3536079	A	Drug metabolism in rat recombinant CYP2E1 assessed as (Z)-N'-hydroxy-6-(5-(5-((Z)-N'-methoxycarbamimidoyl)pyridin-2-yl)furan-2-yl nicotinimidamide formation treated with DB868	Rattus norvegicus	1	ALA3525966	assay format	Scientific Literature
8.	ALA3536452	A	Drug metabolism in rat recombinant CYP2E1 assessed as (3Z,3'Z)-6,6'-(furan-2,5-diyl)bis(N'-hydroxynicotinimidamide) formation treated with DB868	Rattus norvegicus	1	ALA3525966	assay format	Scientific Literature
9.	ALA3784250	A	Drug metabolism in rat liver microsomes assessed as CYP2E1 mediated metabolite M4 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography in presence of clomethiazole	Rattus norvegicus	1	ALA3779870	tissue-based format	Scientific Literature
10.	ALA3784372	A	Drug metabolism in rat liver microsomes assessed as CYP2E1 mediated metabolite M4 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography in presence of CYP1A2 inhibitor alpha-naphthoflavone, CYP2C8 inhibitor quercetin, CYP2C9 inhibitor sulfaphenazole, CYP2C19 inhibitor ticlopidine, CYP2D6 inhibitor quinidine, CYP3A inhibitor ketoconazole	Rattus norvegicus	1	ALA3779870	tissue-based format	Scientific Literature
11.	ALA3782859	A	Drug metabolism in rat liver microsomes assessed as CYP2E1 mediated metabolite M4 formation at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography in presence of ketoconazole	Rattus norvegicus	1	ALA3779870	tissue-based format	Scientific Literature
12.	ALA5118025	A	Inhibition of CYP2E1 in rat liver microsomes using chlorzoxazone as substrate	Rattus norvegicus	1	ALA5113488	microsome format	Scientific Literature